Enanta Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Enanta Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Enanta Pharmaceuticals Inc
Rating: 1.4504305
Author: Trendlyne DVM scores

Momentum Trap

about

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development pro...

13.02 0.22 (1.72%)

218.34% Gain from 52W Low

288.4K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Low Financial Strength

22.2 / 100

Expensive Valuation

15.0 / 100

Technically Neutral

56.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 47%

8 analysts

Enanta Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Enanta Pharma Inc Live Stock Price Today, Share Analysis and Chart

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development pro...

218.34% Gain from 52W Low

SWOT Analysis

Enanta Pharma Inc Live Price Chart